Gut epithelial barriers as regulators of metabolite-driven immune responses
6 affiliations
- 1College of Medicine, Pennsylvania State University Hershey Medical Centre
- 2National Institute of Plant Genome Research
- 3Molecular Pathology Section, Laboratory of Immunogenetics, Division of Intramural Research/National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH)
- 4Department of Cellular and Molecular Physiology, Yale University School of Medicine
- 5University Centre for Research and Development, Chandigarh University
- 6Department of Biochemistry, Central University of Haryana
Abstract
Immunometabolism provides a framework for understanding how metabolic cues shape immune cell fate and function. While traditionally centered on cell-intrinsic pathways, emerging evidence highlights a critical role for epithelial barrier regulation in shaping immune responses by controlling exposure to microbiome derived metabolites. Microbial metabolites including short-chain fatty acids, bile acid derivatives, tryptophan catabolites, and polyamines engage conserved metabolic checkpoints such as mTOR, AMPK, PPARs, SIRT1, and HIF-1α to influence immune activation, tolerance, and inflammatory tone. Critically, epithelial barriers regulate immune exposure to these signals, positioning barrier integrity as an upstream determinant of immunometabolic reprogramming. Altered epithelial metabolism compromises tight junction stability and metabolite flux, contributing to dysregulated immune activation and chronic inflammation. In this review, we synthesize current evidence supporting the concept that epithelial barriers act as metabolic gatekeepers of immunity, integrating microbial signals with host metabolic pathways to regulate immune function and disease susceptibility.
Related
- A stratified human colon model reveals SCFA cross-feeding-driven host–microbe dynamics associated with epithelial and immune responses
- Arabinogalactan Proteins in Pollen–Pistil Interactions: Molecular Regulators of Reproductive Barriers and Compatibility
- High-fat diet-derived metabolite uridine diphosphate (UDP) impairs epithelial regeneration by P2Y 6 -receptor signaling.
- Advances in mechanical force-induced adaptive responses and pathological transition of renal tubular epithelial cells
- APOA1 links a late fetal epithelial program to colonic maturation and injury responses
BibTeX
@article{tyagi2026epithelial,
title = {{Gut epithelial barriers as regulators of metabolite-driven immune responses}},
author = {Anuradha Tyagi and Rajul Tayal and Dharmendra Nath Bhatt and Shivani Srivastava and Anil Kumar and Antresh Kumar and Vinay Kumar},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1959305},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1959305/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Gut epithelial barriers as regulators of metabolite-driven immune responses
AU - Anuradha Tyagi
AU - Rajul Tayal
AU - Dharmendra Nath Bhatt
AU - Shivani Srivastava
AU - Anil Kumar
AU - Antresh Kumar
AU - Vinay Kumar
PY - 2026
DA - 2026/10/27
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1959305
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1959305/full
AB - Immunometabolism provides a framework for understanding how metabolic cues shape immune cell fate and function. While traditionally centered on cell-intrinsic pathways, emerging evidence highlights a critical role for epithelial barrier regulation in shaping immune responses by controlling exposure to microbiome derived metabolites. Microbial metabolites including short-chain fatty acids, bile acid derivatives, tryptophan catabolites, and polyamines engage conserved metabolic checkpoints such as mTOR, AMPK, PPARs, SIRT1, and HIF-1α to influence immune activation, tolerance, and inflammatory tone. Critically, epithelial barriers regulate immune exposure to these signals, positioning barrier integrity as an upstream determinant of immunometabolic reprogramming. Altered epithelial metabolism compromises tight junction stability and metabolite flux, contributing to dysregulated immune activation and chronic inflammation. In this review, we synthesize current evidence supporting the concept that epithelial barriers act as metabolic gatekeepers of immunity, integrating microbial signals with host metabolic pathways to regulate immune function and disease susceptibility.
SN - 1664-3224
ER -